Gene · 55737
Papers2,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of a human induced pluripotent stem cell line NTUHi007-A from a patient with Parkinson's disease harboring a heterozygous missense mutation c.1858 G > A (p.D620N) in VPS35 gene. | Stem Cell Res | 2026 | 41806467 | PubTator, text mining | PubMed |
| Ferroptosis in Parkinson's disease: a review of molecular mechanisms and emerging therapeutic strategies. | Front Neurosci | 2026 | 41799880 | PubTator, text mining | PubMed |
| An explainable ensemble machine learning model using baseline blood transcriptomics to predict Parkinson's disease motor progression. | Front Digit Health | 2026 | 41789394 | PubTator, text mining | PubMed |
| N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models. | J Clin Invest | 2026 | 41766663 | PubTator, text mining | PubMed |
| Literature-driven extraction and computational prediction of causal statements linking genetic variants to biological processes, pathways and phenotypes. | Pac Symp Biocomput | 2026 | 41758181 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| VPS35 Deficiency Markedly Reduces the Proliferation of HEK293 Cells. | Genes (Basel) | 2026 | 41751560 | PubTator, text mining | PubMed |
| Sources of Oxidative Stress in Parkinson's Disease: Pathways and Therapeutic Implications. | Antioxidants (Basel) | 2026 | 41750568 | PubTator, text mining | PubMed |
| Consensus Molecules Associated with Parkinson's Disease. | Neurol Int | 2026 | 41745708 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Core Genes and Construct Diagnostic Model for Alzheimer's Disease. | J Neurochem | 2026 | 41731906 | PubTator, text mining | PubMed |
| Generation of two isogenic control iPSC lines (LCSBi001-A-2 and LCSBi001-A-3) from a Parkinson's disease patient line (LCSBi001-A) carrying the pathogenic VPS35 p.D620N mutation. | Stem Cell Res | 2026 | 41722369 | PubTator, text mining | PubMed |
| Parkinson's Disease: From Gene-Environment Risk to Precision Therapy. | Med Sci (Basel) | 2026 | 41718119 | PubTator, text mining | PubMed |
| [Research progress on the molecular genetic mechanism of Parkinson's disease]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2026 | 41663306 | PubTator, text mining | PubMed |
| The interplay between GBA1 status and age of onset on cognitive, motor and non-motor outcomes in Parkinson's disease: multicenter cross-sectional study. | J Neurol | 2026 | 41621006 | PubTator, text mining | PubMed |
| Proximity labeling in neuroscience: decoding molecular landscapes for precision neurology. | Transl Neurodegener | 2026 | 41606651 | PubTator, text mining | PubMed |
| Engineering an orthogonal ubiquitin transfer cascade with RING E3 RNF38 by phage display to reveal its regulation of nuclear transport. | J Biol Chem | 2026 | 41581872 | PubTator, text mining | PubMed |
| Comprehensive multi-omics analysis and experimental validation indicate that VPS35 is a promising biomarker for prognosis, immunotherapy, and chemotherapy in LIHC. | RSC Med Chem | 2026 | 41531939 | PubTator, text mining | PubMed |
| TDP-43-mediated alternative polyadenylation is associated with a reduction in VPS35 and VPS29 expression in frontotemporal dementia. | PLoS Biol | 2026 | 41490046 | PubTator, text mining | PubMed |
| Structural basis for binding of RILPL1 to TMEM55B reveals a lysosomal platform for adaptor assembly through a conserved peptide motif. | Structure | 2026 | 41314214 | PubTator, text mining | PubMed |
| VPS35 mutation inhibits PINK1/parkin-mediated mitophagy via increased LRRK2 kinase activity. | Brain | 2026 | 41164908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55737/papers?page=2